clinical trial · NCT06282549
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
Essential HypertensionTelmisartan/Amlodipine/Chlorthalidone(Truset)
brief summary
This study is to develop a predictive model for cardiocerebrovascular risk factors in elderly patients with essential hypertension with Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination.
started
Jun 8, 2022
primary completion
Mar 31, 2027
completion
Mar 31, 2027
last updated
Nov 19, 2024
detailed description
This is a phase IV, open-label, prospective, long-term cohort, observational study to identify the predictive model of cardiocerebrovascular risk factors in elderly patients with more than three antihypertensive agents in patients with essential hypertension in Korea.
official title
A Prospective Long-term Cohort Study to Identify the Predictive Model of Cardiocerebrovascular Risk Factors in Elderly Patients with More Than Three Antihypertensive Agents in Patients with Essential Hypertension in Korea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol